GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (FRA:UNJ) » Definitions » PB Ratio

United Laboratories International Holdings (FRA:UNJ) PB Ratio : 1.14 (As of Apr. 29, 2024)


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-29), United Laboratories International Holdings's share price is €1.03. United Laboratories International Holdings's Book Value per Share for the quarter that ended in Jun. 2023 was €0.90. Hence, United Laboratories International Holdings's PB Ratio of today is 1.14.

The historical rank and industry rank for United Laboratories International Holdings's PB Ratio or its related term are showing as below:

FRA:UNJ' s PB Ratio Range Over the Past 10 Years
Min: 0.52   Med: 1.09   Max: 2.36
Current: 1.24

During the past 13 years, United Laboratories International Holdings's highest PB Ratio was 2.36. The lowest was 0.52. And the median was 1.09.

FRA:UNJ's PB Ratio is ranked better than
69.85% of 962 companies
in the Drug Manufacturers industry
Industry Median: 1.925 vs FRA:UNJ: 1.24

During the past 12 months, United Laboratories International Holdings's average Book Value Per Share Growth Rate was 10.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 13.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 11.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 5.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of United Laboratories International Holdings was 24.50% per year. The lowest was -2.60% per year. And the median was 9.50% per year.

Back to Basics: PB Ratio


United Laboratories International Holdings PB Ratio Historical Data

The historical data trend for United Laboratories International Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings PB Ratio Chart

United Laboratories International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 0.94 0.65 0.71 0.88

United Laboratories International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.71 0.71 0.90 0.88

Competitive Comparison of United Laboratories International Holdings's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's PB Ratio falls into.



United Laboratories International Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

United Laboratories International Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=1.03/0.9
=1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


United Laboratories International Holdings  (FRA:UNJ) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


United Laboratories International Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (FRA:UNJ) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (FRA:UNJ) Headlines

No Headlines